News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Stryker Corp (SYK) shares rose 3.1% on July 23, 2026, despite a year-to-date decline, and are considered 23.0% undervalued with a strong GF Score of 92/100. Despite this, insiders have sold $100.7 million in stock recently, raising caution for potential investors. The company's GF …
Sharemaestro market context Price above Trend Line 52 weeks -13.3%Stryker Corp (SYK) saw its stock close up by 3.21% on July 23, driven by a strong second-quarter earnings report that surpassed analyst expectations, showcasing significant growth in MedSurg and Neurotechnology. Management's raised full-year earnings guidance, reflecting a bullish outlook on hospital spending and …
In March 2026, Iranian hackers executed a destructive cyberattack on Stryker, a U.S. medical technology company, wiping tens of thousands of employee devices. This incident signifies a significant shift in Iranian cyber operations from traditional espionage to direct destructive attacks, likely in retaliation for …
Boston Scientific Corp. and Stryker Corporation have reached an agreement in principle to settle their patent dispute concerning a surgical device used for treating chronic lower back pain. This development follows Boston Scientific's unsuccessful attempt to block sales of Stryker’s competing product. The case …
Stryker Corp. (SYK) shares fell by 1.70% on Wednesday, closing at $309.24. This underperformance occurred during a generally negative trading session, with the S&P 500 Index and Dow Jones Industrial Average also declining. This marked the fourth consecutive day of losses for Stryker's stock.
Stryker Corporation's stock maintains a stable valuation due to strong recent earnings and strategic investments in surgical robotics and other medtech platforms. The company reported significant revenue growth and increased adjusted earnings per share, driven by demand for orthopedic and neurotechnology products. Consistent R&D …
Stryker has announced the full U.S. commercial launch of its Mako RPS (Robotic Power System) for total knee replacement procedures, expanding its Mako portfolio into a new category of orthopedic robotics. This marks the introduction of the Mako Handheld Robotics platform, designed to offer …
Stryker stock's current trading is analyzed based on its latest reported revenue, profit, and margin figures, as concrete market data was unavailable for real-time analysis. The article focuses on the company's established financial performance rather than speculative product information or unverified market movements. It …
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Stryker stock has given investors a 28.3% total return over the past five years, yet its current price around US$319.87 sits at a point …
Sharemaestro market context Price above Trend Line 52 weeks -17.5% · Next-week setup negative 41.0%Stryker (SYK) stock has experienced a 28.3% total return over the last five years, yet its current price of around US$319 suggests potential undervaluation according to a Discounted Cash Flow (DCF) model, which estimates an intrinsic value of $402 per share. However, its P/E …
Sharemaestro market context Price above Trend Line 52 weeks -17.5% · Next-week setup negative 41.0%On 16 July 2026, Stryker announced the U.S. commercial launch of Mako RPS, a handheld robotic system for total knee replacement that combines intraoperative planning with a robotically enabled saw and integrates with its Triathlon Total Knee System and Q Guidance platform. This move …
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Stryker (SYK) has drawn fresh attention after announcing the U.S. commercial launch of Mako RPS, a handheld robotic system for total knee replacements …
Stryker Corp. (SYK) shares fell 3.42% to $319.87 on Friday, ending a two-day winning streak. This underperformance occurred during a generally negative trading session, with the S&P 500 Index dropping 1.01% and the Dow Jones Industrial Average falling 0.77%.
Stryker Corp (SYK) stock declined by 3.42% on July 17th due to concerns about orthopedic demand, hospital capital spending, and elevated treasury yields affecting valuation multiples for high-growth medical technology firms. Technical breaches of support levels and institutional profit-taking also contributed to its intraday …
Sharemaestro market context Price above Trend Line 52 weeks -13.3%Stryker's stock is trading near its highs, supported by strong demand for orthopedic implants and surgical robotics. The company reported robust 2024 fiscal results with double-digit revenue growth in key segments like MedSurg, Neurotechnology, Orthopaedics,
Stryker has launched Mako RPS (Robotic Power System), a handheld robotic platform for total knee replacement procedures, expanding its Mako robotics portfolio. This new system integrates with the Triathlon Total Knee System and Q Guidance System, aiming to simplify robotic-assisted surgery for surgeons and …
This page provides comprehensive financial data, news, and analysis for Stryker Corp (XTER:SYK), a medical equipment manufacturer. It details current stock price, market cap, various financial ratios, growth rates, profitability ranks, and upcoming earnings dates. The company designs, manufactures, and markets a wide array …
Sharemaestro market context Price above Trend Line 52 weeks -17.5% · Next-week setup negative 41.0%Stryker's shares increased following the commercial launch of its Mako Robotic Power System. The system received FDA 510(k) clearance in August 2017 and is designed for total knee replacement procedures, aiming to enhance surgical precision and patient outcomes. The company plans a controlled release …
Stryker (SYK) is facing scrutiny after a cyberattack by Iranian hackers caused disruptions, temporarily halting order processing and production worldwide. Despite a recent share price rise, its year-to-date and one-year returns are negative, suggesting the cyberattack and softer capital equipment spending are weighing on …
Sharemaestro market context Price above Trend Line 52 weeks -17.5% · Next-week setup negative 41.0%Stryker (NYSE: SYK) has announced the U.S. commercial launch of its Mako RPS (Robotic Power System) for total knee replacement, expanding its Mako portfolio into a new category of handheld orthopaedic robotics. This system combines intraoperative planning with a robotically enabled saw, compatible with …
Stryker has announced the U.S. commercial launch of Mako RPS (Robotic Power System) for total knee replacement procedures, expanding its Mako robotics portfolio. This new handheld robotics platform offers surgeons an intuitive experience and integrates with Stryker's Triathlon Total Knee System. The launch aims …
RBC Capital has reiterated its Buy rating on Stryker Corp (SYK.US) and maintained its price target of $435. This indicates a continued positive outlook on the company's stock performance from the analytical firm.
Stryker (SYK) is positioned to leverage rapid growth in the nerve repair biomaterials sector, which could enhance its neurotechnology portfolio and international expansion, particularly in Asia-Pacific. The company's investment narrative projects significant revenue and earnings growth by 2029, suggesting a fair value upside. However, …
Sharemaestro market context Price above Trend Line 52 weeks -17.5% · Next-week setup negative 41.0%Search by ticker symbol or company name and select a result to open its chart.